Amyloidosis

Patients across the nation, and worldwide, come to the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian/Columbia University Medical Center for truly individualized care.

Our program, recognized by the National Cancer Institute as a designated comprehensive cancer center, provides access to specialists in every discipline, and offers the kind of in-depth expertise only possible at a major academic medical institution. Our physicians are global leaders in innovative technologies, genetics, clinical trials and "bench to bedside" research, allowing us to offer the most advanced therapies for amyloidosis.